Fig. 2From: Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxabanCorrelation between two miRNAs and AXA3h (A) or AUC0-t (B). AXA3h, anti-Xa activity measured 3 h after rivaroxaban administration; AUC0-t: the area under the plasma concentration–time curve from time 0-t hBack to article page